
The company’s investment strategy is aimed at the investigation, production development and import substitution of medicines and vaccines used in socially significant areas of medicine, such as oncological, autoimmune, infectious and orphan diseases.

The product portfolio includes original pharmaceutical products, contract medicines and food supplements

R&D center, patents for molecules and pharmaceutical manufacturing technologies in Russia and abroad

Modern biotechnological production in accordance with the EAEU and EU GMP standards

One of the largest exporters of original pharmaceutical products and vaccines for the prevention of influenza

Partner of international Big Pharma companies: Pfizer, Abbott, Boehringer Ingelheim, ISU ABXIS
the structure of Petrovax
-
R&D center
-
BD department
-
Clinical studies and product registration
-
Administration Office
-
API & Finished-dose
-
Manufacturing Site
-
Quality Control
-
Marketing and Sales Force
-
Pharmacovigilance
The company was founded in 1996 by a team of Russian scientists.

Innovative products for health and better quality of life
